Managed Access Programs for ETB115, Eltrombopag
ConditionThrombocytopenia
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age18-99
SponsorNovartis Pharmaceuticals
About this trial
The purpose of this registration is to list Managed Access Programs (MAPs) related to ETB115, Eltrombopag
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
Eltrombopag
DrugPatients receive eltrombopag
Treatment groups
No treatment groups listed
Trial outcomes
This trial has no outcomes listed.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov